Patient Conditions/Disease States

Hemophilia is a disorder where the blood does not clot properly. This is due to the body not having enough blood-clotting proteins. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. They are two types of hemophilia. Hemophilia A and Hemophilia B. Hemophilia A is caused by the lack of low level or clotting factor VIII. Hemophilia B is caused by the lack or low level of clotting factor IX.

Chronic Kidney Disease is when the kidneys gradually get damaged over time and the kidneys are unable to complete functions such as removing wastes from your body, maintain blood pressure, and keeping your bones healthy.

Breast cancer is the most common cancer diagnosed in the US, and it is also the most common cancer diagnosed worldwide. In the US alone, approximately 4 million women are diagnosed with the disease.

Host Fred Goldstein invites Brian Hilberdink, President, Executive Vice President North America and Douglas Maslin, MD, Global Principal Medical Advisor to discuss LEO Pharma and their involvement with AMCP.

In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to the abnormal production of amyloid proteins.

In this video, Bethany from Ohio shares her health journey with schizophrenia and depression, and side effects from going off her medication. She spent a year trying different anti-psychotic medications.

In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to the abnormal production of amyloid proteins.

In this video, Sandy from North Carolina shares her health journey with alopecia, an autoimmune condition that causes hair loss.

In this webinar, you'll explore the impact of RSV on U.S. infants, examine key clinical studies on nirsevimab, and review global real-world data on its effectiveness. You'll also learn how to implement immunization strategies to reduce RSV lower respiratory tract infections (LRTI), with practical takeaways for improving coverage and reimbursement decisions.

The Academy of Managed Care Pharmacy (AMCP) reflects on a year marked by triumphs, innovation and notable acheivements and looks forward toward the potential opportunities and challenges awaiting managed care professionals in 2024.